Skip to main content

Want a detailed portfolio tracker?

PMGC (ELAB) P/E (2023 - 2026)

PMGC (ELAB) P/E from Nov 21, 2023 to Jul 21, 2026. The TTM PMGC (ELAB) P/E is -0.02. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of PMGC (ELAB)

YearP/EChange
2026-0.02-97.04%
2025-0.61-98.47%
2024-39.59-5.12%
2023-41.73N/A

Comparison PMGC (ELAB) P/E with competitors

PMGC (ELAB) P/E is -0.02.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-109.48%
NBYStablecoin Development Corp0.00-123.97%
ENLVEnlivex Ltd0.07-516.95%
FGENFibroGen Inc0.24-1438.01%
CHRSCoherus Biosciences Inc0.85-4829.76%
FBIOFortress Biotech Inc0.95-5389.97%
ORMPOramed Pharmaceuticals Inc1.50-8478.11%
AGENAgenus Inc3.01-16875.73%
INVAInnoviva Inc3.15-17680.65%
VXRTVaxart Inc3.55-19886.39%
CRMDCorMedix Inc3.63-20325.08%
CVACCureVac N.V.4.45-24880.36%
GLPGGalapagos NV4.86-27183.65%
SRPTSarepta Therapeutics Inc4.88-27312.97%
ABEOAbeona Therapeutics Inc5.39-30130.20%
ABUSArbutus Biopharma Corp5.60-31290.20%
ZVRAZevra Therapeutics Inc5.89-32915.66%
SPROSpero Therapeutics Inc6.23-34817.59%
CGENCompugen Ltd6.31-35294.19%
RIGLRigel Pharmaceuticals6.87-38405.18%
SLXNSilexion Therapeutics Corp7.30-40768.67%
OMEROmeros Corporation9.26-51708.71%
AUPHAurinia Pharmaceuticals Inc9.58-53527.03%
PLXProtalix BioTherapeutics Inc10.89-60807.01%
ACADAcadia Pharmaceuticals Inc11.73-65475.45%
TBPHTheravance Biopharma Inc12.26-68449.88%
ADMAAdma Biologics Inc12.42-69319.46%
HRMYHarmony Biosciences Holdings Inc13.82-77134.57%
SABSSAB Biotherapeutics Inc14.14-78896.04%
NAGENiagen Bioscience Inc14.82-82697.12%
INCYIncyte Corp15.82-88295.91%
REGNRegeneron Pharmaceuticals Inc15.86-88485.99%
PBYIPuma Biotechnology Inc17.32-96618.83%
CPRXCatalyst Pharmaceuticals Inc17.44-97307.81%
EXELExelixis Inc17.54-97857.99%
TGTXTG Therapeutics Inc18.97-105818.03%
MDXGMimedx Group Inc20.55-114661.03%
XOMAXOMA Royalty Corp22.87-127608.36%
ARGXArgen X SE24.30-135542.20%
CTMXCytomX Therapeutics Inc24.82-138458.09%
XOMAOXOMA Royalty Corp25.34-141377.33%
HALOHalozyme Therapeutics Inc25.62-142931.99%
XOMAPXOMA Royalty Corp25.67-143190.64%
VRTXVertex Pharmaceuticals Inc27.99-156148.56%
RPRXRoyalty Pharma plc - Class A28.69-160010.40%
SLNOSoleno Therapeutics Inc29.02-161837.65%
ASNDAscendis Pharma A/S30.09-167803.22%
LGNDLigand Pharmaceuticals Inc - Class B37.91-211429.59%
APLSApellis Pharmaceuticals Inc39.02-217612.55%
BMRNBiomarin Pharmaceutical Inc42.21-235397.78%
KRYSKrystal Biotech Inc45.34-252854.13%
ONCBeiGene Ltd69.54-387733.33%
PHARPharming Group N.V.75.03-418308.69%
TECHBio-Techne Corp101.96-568437.94%
VCELVericel Corp109.92-612825.20%
ALNYAlnylam Pharmaceuticals Inc117.96-657662.86%
GMABGenmab140.29-782110.95%
TLXTelix Pharmaceuticals Ltd162.15-903974.82%
CORTCorcept Therapeutics Inc212.86-1186613.65%